EX-2.1
from 8-K
107 pages
Amended and Restated Agreement and Plan of Merger by and Among Myriad Genetics, Inc., Myriad Crescendo, Inc., Crescendo Bioscience, Inc. and MDV IX, L.P., as Representative Dated as of February 2, 2014
12/34/56
EX-2.1
from 8-K
89 pages
Agreement and Plan of Merger by and Between Rules-Based Medicine, Inc., Myriad Genetics, Inc., Myriad Rbm, Inc. and Mark Chandler, PH.D., as Representative April 27, 2011
12/34/56
